S1PR1 is up-regulated in several autoimmune diseases such as multiple sclerosis, systemic lupus erythematosus or rheumatoid arthritis and agents which inhibit S1PR1 are being investigated for their therapeutic potential (46). Here, S1PR1 is linked to multiple sclerosis.